14-39240565-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000640607.2(MIA2):c.254G>A(p.Gly85Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000678 in 1,608,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00024 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000049 ( 0 hom. )
Consequence
MIA2
ENST00000640607.2 missense
ENST00000640607.2 missense
Scores
3
8
8
Clinical Significance
Conservation
PhyloP100: 4.11
Genes affected
MIA2 (HGNC:18432): (MIA SH3 domain ER export factor 2) This gene encodes s receptor in the endoplasmic reticulum, which plays a role in the export of large pre-chylomicrons and pre-very low density lipoproteins (pre-VLDLs). Three major classes of transcripts are generated from this gene- melanoma inhibitory activity 2-specific transcripts, cTAGE family member 5-specific transcripts and transcripts that include exons from both these transcript species (TANGO1-like or TALI). Additionally, alternative splicing in these transcripts results in multiple transcript variants encoding multiple isoforms. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.067840815).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIA2 | NM_001329214.4 | c.254G>A | p.Gly85Glu | missense_variant | 3/29 | ENST00000640607.2 | NP_001316143.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIA2 | ENST00000640607.2 | c.254G>A | p.Gly85Glu | missense_variant | 3/29 | 1 | NM_001329214.4 | ENSP00000491014 | P2 | |
MIA2 | ENST00000280082.4 | c.254G>A | p.Gly85Glu | missense_variant | 3/6 | 1 | ENSP00000280082 | |||
MIA2 | ENST00000553728.1 | c.254G>A | p.Gly85Glu | missense_variant | 3/28 | 5 | ENSP00000452252 | A2 | ||
MIA2 | ENST00000557148.5 | c.254G>A | p.Gly85Glu | missense_variant | 5/5 | 5 | ENSP00000451883 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152184Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
37
AN:
152184
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000160 AC: 40AN: 250330Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135266
GnomAD3 exomes
AF:
AC:
40
AN:
250330
Hom.:
AF XY:
AC XY:
16
AN XY:
135266
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000494 AC: 72AN: 1456524Hom.: 0 Cov.: 28 AF XY: 0.0000428 AC XY: 31AN XY: 724892
GnomAD4 exome
AF:
AC:
72
AN:
1456524
Hom.:
Cov.:
28
AF XY:
AC XY:
31
AN XY:
724892
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000243 AC: 37AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74480
GnomAD4 genome
AF:
AC:
37
AN:
152302
Hom.:
Cov.:
33
AF XY:
AC XY:
14
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
23
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2024 | The c.254G>A (p.G85E) alteration is located in exon 3 (coding exon 3) of the MIA2 gene. This alteration results from a G to A substitution at nucleotide position 254, causing the glycine (G) at amino acid position 85 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
.;.;M;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;.
REVEL
Benign
Sift
Benign
T;D;T;.
Sift4G
Pathogenic
D;D;D;.
Polyphen
0.87, 0.89
.;.;P;P
Vest4
0.27, 0.31
MVP
MPC
0.18
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at